Gerald Proehl's Trading History
| DRMADermata Therapeutics | Aug 18, 2026 | PRESIDENT, CHAIRMAN, CEO, Director, Ten Percent Owner | Uninformative Buy | ― | $288.78K | |
| TENXTenax Therapeutics | Aug 08, 2024 | Director | Uninformative Buy | ― | $2.98K | |
| FFRFF EAI Robotics Ecosystem Inc | Jun 25, 2015 | Director | Informative Buy | 250.00K | $50.50K | |
| ASPXAuspex Pharma | May 05, 2015 | ― | Uninformative Sell | ― | ― | |
| SPHSSophiris Bio | Sep 19, 2014 | ― | Informative Buy | 31.50K | $120.00 | |
| SNTSSantarus | Jan 06, 2014 | ― | Uninformative Sell | 18.98M | ― | |
| ASRTAssertio Therapeutics | ― | ― | ― | $0.00 |
You May Also Like
Gerald Proehl insider profile FAQ
What is the percentage of profitable transactions made by Gerald Proehl?
The percentage of profitable transactions made by Gerald Proehl is 0%.
What is the average return per transaction made by Gerald Proehl?
The average return per transaction made by Gerald Proehl is -73.50%.
What stocks does Gerald Proehl hold?
Gerald Proehl holds: DRMA, TENX, FFR, SPHS, ASPX, SNTS, ASRT stocks.
What was Gerald Proehl's most profitable transaction?
Gerald Proehl’s most profitable transaction was an Informative Buy of SPHS stock on September 19, 2014. The return on the trade was -64.30%.
What is Gerald Proehl's role in Dermata Therapeutics?
Gerald Proehl's role in Dermata Therapeutics is PRESIDENT, CHAIRMAN, CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.